BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

AstraZeneca Reports Positive Phase 3 Results For Tozorakimab In COPD

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozoraki...

March 30, 2026 | News

Bioptimus Launches STELA Initiative To Build World’s Largest Multimodal Atlas For AI Driven Biology

The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale...

March 27, 2026 | News

Infosys To Acquire Optimum Healthcare IT To Strengthen AI Led Healthcare Transformation

Acquisition to unlock AI-powered cloud and digital transformation for healthcare providers Infosys a global leader in next-generation digital ...

March 27, 2026 | News

GI Innovation Enters Clinical Supply Agreement With Johnson And Johnson To Advance Prostate Cancer Combination Therapy

GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy...

March 23, 2026 | News

Everest Medicines Eyes Strategic Asia Expansion With Proposed Hasten Singapore Acquisition

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

March 19, 2026 | News

Codex Genetics And C2N Diagnostics Partner To Expand Alzheimer’s Blood Test Access In Hong Kong

Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a...

March 11, 2026 | News

China Clears IND For Harbour BioMed And Kelun Biotech Bispecific Antibody For Atopic Dermatitis

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology an...

March 10, 2026 | News

Fujitsu And DT Axis Partner To Accelerate Software As Medical Device Development In Japan

Fujitsu Limited and DT-Axis Co., Ltd. announced the commencement of a collaboration aimed at advancing digital health. The two companies have signed a memo...

March 10, 2026 | News

Datasea Expands Acoustic AI Healthcare Robot Partnership To Accelerate Commercial Deployment

Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-tech innovation and AI-driven multimodal...

March 09, 2026 | News

Servier To Acquire Day One Biopharmaceuticals For $2.5 Billion To Strengthen Rare Oncology Pipeline

Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric cancers with...

March 09, 2026 | News

Thermo Fisher Opens Advanced Distribution And Labelling Centre In Uppsala To Strengthen Global Immunodiagnostics Supply

Thermo Fisher Scientific Inc., the world leader in serving science, announced the opening of a new 8,000-square-meter distribution and labeling center supp...

March 05, 2026 | News

Thermo Fisher Launches TacroType Pharmacogenetic Test To Personalise Tacrolimus Dosing In Transplant Care

TacroType™ Pharmacogenetic Test designed to support more personalized tacrolimus dosing, assisting clinical decision-making in solid organ ...

March 03, 2026 | News

Pfizer And Astellas Report Strong Phase III EV 304 Results For PADCEV Plus Pembrolizumab In MIBC

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with ove...

March 02, 2026 | News

Optellum Secures TGA Approval In Australia For AI Powered Virtual Nodule Clinic

Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration ...

March 02, 2026 | News

Stay Connected